Accuray | ARAY - Les Charges D'Exploitation

Prix De L'Action
0.44
Variation Quotidienne
-0.03 -5.50%
Mensuellement
14.77%
Annuel
-71.34%
Q2 Prévisions
0.43




Les Charges D'Exploitation Changement Date
Abbott USD 9.31B 104M 2026-03
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Inogen USD 49.14M 665K 2024-09
Mesa Laboratories USD 33.98M 2.03M 2024-12
Orthofix International USD 213.79M 12.36M 2025-12
Surmodics USD 29.51M 274.86M 2025-06
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Trinity Biotech USD 14.82M 7.81M 2025-09